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Abstract
Background: Naturally acquired immunity to malaria may be lost with lack of exposure. Recent heterogeneous
reductions in transmission in parts of Africa mean that large populations of previously protected people may lose
their immunity while remaining at risk of infection.
Methods: Using two ethnically similar long-term cohorts of children with historically similar levels of exposure to
Plasmodium falciparum who now experience very different levels of exposure, we assessed the effect of decreased
parasite exposure on antimalarial immunity. Peripheral blood mononuclear cells (PBMCs) from children in each cohort
were stimulated with P. falciparum and their P. falciparum-specific proliferative and cytokine responses were compared.
Results: We demonstrate that, while P. falciparum-specific CD4+ T cells are maintained in the absence of exposure, the
proliferative capacity of these cells is altered considerably. P. falciparum-specific CD4+ T cells isolated from children
previously exposed, but now living in an area of minimal exposure (“historically exposed”) proliferate significantly more
upon stimulation than cells isolated from children continually exposed to the parasite. Similarly, PBMCs from historically
exposed children expressed higher levels of pro-inflammatory cytokines and lower levels of anti-inflammatory
cytokines after stimulation with P. falciparum. Notably, we found a significant positive association between
duration since last febrile episode and P. falciparum-specific CD4+ T cell proliferation, with more recent febrile
episodes associated with lower proliferation.
Conclusion: Considered in the context of existing knowledge, these data suggest a model explaining how immunity
is lost in absence of continuing exposure to P. falciparum.
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Background
Malaria remains a significant threat to human health.
While it is difficult to estimate attributable numbers of
cases and deaths, the recent WHO report suggests at
least 198 million cases were reported in 2013, leading to
approximately 584,000 deaths [1]. A large proportion of
this burden is borne by Africa, where despite massive
investments in malaria control and prevention, 57 % of
the population continue to live in areas of moderate to
intense malaria transmission [2].
Studies in malaria endemic areas consistently demon-
strate that incidence and severity of disease decreases
significantly with age, indicating that individuals living
in these areas acquire a degree of immunity to clinical
malaria. This protection is, however, only acquired
following repeated infections and is not sterile [3, 4].
Although the mechanisms that underpin naturally
acquired immunity to malaria (NAI) remain poorly
understood, a review of literature suggests that it is
comprised of two main components, namely (1) an
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anti-parasite component resulting in control of para-
site replication and parasite clearance [5, 6] and (2) the
ability to tolerate parasites asymptomatically. The latter
component is likely to include an immunoregulatory
(immune tolerance) element that contributes to control
of symptoms and clinical immunity [7, 8]. Antibody-
dependent mechanisms play a major role in parasite
control and clearance [5], with contributions from innate
and cellular arms of immunity [6]. In contrast, the mecha-
nism for the establishment of Plasmodium falciparum-
specific immune “tolerance” is less understood. Recent
studies suggest that repeated exposure to P. falciparum, as
experienced in areas of high malaria endemicity, is re-
quired for the establishment of tolerance [7], which may
be associated with the loss and/or altered function of
several immune cell types, including γδ T cells [8], αβ T
cells [9–12], B cells [13], and myeloid cells [14]. Repeated
exposure also results in an expansion of “self-regulating”
Th1 cells [7, 15, 16], which produce IL-10 in combination
with IFN-γ. IL-10 is a key immunomodulatory cytokine
and plays an important role in mouse models of malaria
[17–19]. Continual exposure to P. falciparum therefore
appears to result in modulation of inflammation and asso-
ciated immunopathology through regulation at multiple
levels of the immune system.
Unfortunately, individuals who acquire immunity in
malaria endemic areas but then migrate to malaria-free
regions for prolonged periods appear to be susceptible
to clinical disease upon returning to the endemic region
[20–22]. This loss of immune protection may reflect de-
fective antimalarial immunity related to poor induction
and maintenance of long-lived memory responses [22].
However, while protective plasma antibody levels decay
rapidly (especially in young children) [23, 24], rapid
boosting of antibody responses to a number of P. fal-
ciparum antigens have been reported upon re-exposure
following periods of no exposure [25, 26]. In agreement
with this, we have previously demonstrated that, while
P. falciparum-specific antibody levels fall to undetect-
able levels in the absence of persistent P. falciparum
exposure, P. falciparum-specific memory B cells are
maintained at similar levels to those found in children
continually exposed to the parasite [27]. Furthermore,
one might also infer a loss of tolerance to parasitemia
from observations of the cytokine profiles of previously
immune, returning travelers [28] and from the fact that
these individuals appear to become unwell at parasite
densities that they might previously have tolerated
asymptomatically [29].
The mechanism(s) by which P. falciparum-specific T
cell memory is induced and maintained is poorly under-
stood. While some reports have described impairments in
the establishment of P. falciparum-specific T cell memory
(stemming from antigenic diversity [30], infection-related
depletion of antigen-specific T cells [31, 32], and im-
paired dendritic cells [33]), animal models suggest that
P. falciparum-specific memory T cell populations are
maintained normally after infection. To date, only one
study has directly assessed the longevity of P. falciparum-
specific T cell responses in humans following a period of
minimal exposure. This study measured P. falciparum-
specific responses in adults living in an area of low malaria
endemicity in Northern Thailand and demonstrated that,
while some antimalarial T cell responses (IFN-γ producing
T cells) were relatively short-lived, others (IL-10 producing
T cells) were maintained for much longer in the absence
of exposure [34]. The limitation of this study, however,
was that the majority of the malaria-exposed individuals
had experienced only one documented episode of malaria
in their lifetime. Given the previously described role that
endemic malaria has in shaping the P. falciparum-specific
T cell response [8–12], it is reasonable to suspect that the
longevity of memory responses established in individuals
previously living in malaria endemic regions (and continu-
ally exposed to P. falciparum) may differ significantly from
those established in individuals only infrequently exposed
to malaria.
In this study, we determined the effect of diminished ex-
posure on the size and function of P. falciparum-specific
T cell memory responses by studying a unique epidemio-
logical “natural experiment” on the coast of Kenya. Here,
two ethnically and culturally similar cohorts of children
with historically endemic exposure to P. falciparum now
experience very different levels of exposure. While one
group of children has remained continually exposed over
the past 8 years (“continually exposed” cohort in Junju),
the other has experienced a dramatic reduction in
malaria transmission such that exposure has been min-
imal for over 8 years prior to sampling (“historically ex-
posed” cohort in Ngerenya). By performing a detailed
functional characterization of P. falciparum-specific T
cell responses found in these two otherwise similar
groups of children, we hoped to gain insight into the
fate of P. falciparum-specific T cell immunity as exposure
to P. falciparum declines. We demonstrate that lack of
continuing exposure in the historically exposed cohort
resulted in increased levels of P. falciparum-specific




The study took place at the KEMRI-Wellcome Trust
Research Programme (KWTRP) situated at the Kilifi
County Hospital, Kilifi, Kenya. The hospital serves ap-
proximately 500,000 people living in Kilifi County. The
children investigated were residents of two villages,
located within 20 km of each other, with Junju lying on
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the southern side and Ngerenya on the northern side
of an Indian Ocean creek inhabited predominantly by
Mijikenda people.
Study population
Peripheral blood mononuclear cell (PBMC) samples
were collected as part of ongoing surveillance of chil-
dren enrolled in two cohorts at KWTRP in Kilifi, Kenya.
Over the last 15 years, there has been a gradual, hetero-
geneous decline in malaria transmission in Kilifi County
[35, 36], whereby Junju village remains stably endemic
with two high transmission seasons (May to August and
October to December) and a parasite prevalence of 30 %
[37, 38] during the dry season, while in Ngerenya
(20 km North), parasite prevalence has dramatically re-
duced from endemic levels of 40 % in 1998, to less than
1 % since 2005 [39]. Children are recruited into the co-
horts at birth and actively monitored on a weekly basis
for detection of malaria episodes until 15 years of age.
Extensive and detailed records of the number and dates
of malaria episodes for each child over the period they
are enrolled in the cohort are maintained. For this
analysis, historically exposed children were selected from
Ngerenya on the basis of having confirmed prior exposure
to malaria (at least one clinical episode) and matched to
continually exposed children of similar age in Junju
(Table 1).
Sample collection and preparation
Venous blood (5 mL; for immunological studies) and
blood smears (for detection and subsequent calculation
of P. falciparum parasitemia) were collected from each
participant in a preseason cross-sectional survey in
May 2012, a time preceded by 4 months of minimal P.
falciparum transmission in Junju. PBMCs were isolated
by density gradient centrifugation (Ficoll-Histopague,
GE Life Sciences) and stored in liquid nitrogen till the
assays were performed.
Determination of parasitemia
Thick and thin blood smears were stained with Giemsa
and P. falciparum-infected red cells counted against 500
leukocytes and 1000 red blood cells, respectively. To
further confirm that previously exposed children were
uninfected, a P. falciparum-specific PCR was performed,
as previously described [40].
Malaria antigen
P. falciparum blood-stage parasites (laboratory-adapted
local field isolate) were grown by standard methods and
harvested at 5–10 % parasitemia. Red blood cells infected
(iRBC) with trophozoite stage parasites were purified via
density gradient centrifugation using Percoll (GE, Life
Sciences) washed and cryopreserved in glycerolyte. A
single batch of parasites was used throughout the study.
Aliquots of this batch were stored in liquid nitrogen until
required. Uninfected red blood cells (uRBC) were pre-
pared and stored in a similar manner for use as controls.
Intracellular cytokine staining
Thawed PBMCs were rested overnight in media sup-
plemented with 10 % fetal bovine serum (Gibco) and
restimulated with media, uRBCs, iRBCs, and plate-
bound anti-CD3 (BioLegend) at 7.5 × 105 cells per con-
dition. An effector-to-target ratio of 1:3 was used with
uRBCs and iRBCs. Anti-CD28 and anti-CD49d were
added for co-stimulation (3 μg/mL BioLegend). Brefeldin
A (BD Pharmingen) was added at 6 hours of incubation at
a final concentration of 10 μg/mL to inhibit cytokine
secretion. At 24 hours, cells were washed, surface stained,
fixed, permeabilized, and stained for intracellular cyto-
kines per standard protocols (BD Pharmingen).
Surface and intracellular staining of PBMCs was done
with standard staining protocols using the following
antibodies: fluorescein isothiocyanate (FITC)-conjugated
anti-CD45RO, allophycocyanin (APC)-Cy7-conjugated
anti-CD3, Brilliant Violet 421-conjugated anti-IL-10
(panel 1), Brilliant Violet 421-conjugated anti-TNF-α
(panel 2), phycoerythrin (PE)-conjugated anti-IL-4 (panel 2),
APC-conjugated anti-CCR7 (BioLegend), PerCP-Cy5.5-
conjugated anti-CD8, PE-Cy7-conjugated-anti CD27, PE-
conjugated anti-IFN-γ (panel 1) (BD Phamingen), and
PE-Texas Red-conjugated CD4 (Invitrogen). LIVE/DEAD
aqua amine was included to exclude dead cells from down-
stream analysis (although the malaria specific analysis did
not include CD8+ T cells, they were stained to facilitate
Table 1 Characteristics of study cohorts
Variable Ngerenya Junju
Total number 44 44
Sex (%)
Male 26 (59) 18 (41)
Female 20 (45) 24 (55)
Age (years)
Mean (95 % CI) 11.09 (10.66–11.51) 11.16 (10.75–11.57)
Range 7.16–12.94 7.35–12.99
Total no. of previous P. falciparum episodes
Mean (95 % CI) 2.64 (2.01–3.26) 4.48 (3.35–5.60)
Range 1–9 1–16
Time since last episode (mo)
Median (IQR) 105.8 (78.17–112.5) 12.1 (4.2–36.67)
Range 3.23–143.6 2.03–83.1
P. falciparum infection status at sampling (% positive)
By blood smear 1 (2.2) 11 (25)
By PCR 1 (2.2) 15 (34)
Bediako et al. BMC Medicine  (2016) 14:143 Page 3 of 11
gating on CD4+CD8– T cells) (see Additional file 1:
Table S1 for complete panel).
CFSE proliferation assay
Thawed PBMCs were rested overnight in media supple-
mented with 10 % fetal bovine serum. Cells were washed
and 1 × 106 cells were labeled with 1 mL of 5 μM CFSE
(BioLegend) following an established protocol reported
elsewhere [41]. CFSE-labeled PBMCs were incubated in
a 96-well culture plate and stimulated with media,
uRBCs, iRBCs, and plate-bound anti-CD3 (BioLegend)
at a density of 2.5 × 105 cells per condition. As before, an
effector-to-target ratio of 1:3 was used with uRBCs and
iRBCs. Anti-CD28 and anti-CD49d were added for costi-
mulation (3 μg/mL BioLegend). At day 7, supernatants
were collected and frozen for downstream cytokine
analysis and the cells washed and stained with surface
antibodies (Brilliant Violet 421-conjugated anti-CD4,
APC-conjugated anti-CCR7, APC-Cy7-conjugated anti-
CD3 (BioLegend), PE-Cy7-conjugated anti-CD27, and
PerCP-Cy5.5-conjugated anti-CD8 (BD Pharmingen))
before acquisition. Once again, LIVE/DEAD aqua amine
was included to exclude dead cells from downstream
analysis.
Flow cytometry
Cytokine production by CD4+ T cells was analyzed using
two panels; panel 1: IFN-γ and IL-10; panel 2: IL-4 and
TNF-α (both panels assessed surface expression of a
number of markers of CD4+ T cell memory phenotype).
At least 100,000 lymphocytes were acquired on a 9-color
Cyan ADP flow cytometer (Beckman Coulter). Color com-
pensations were performed using samples stained for each
of the fluorochromes used. Data were analyzed using
FlowJo (Tree Star). Percentages of iRBC-stimulated cyto-
kine producing CD4+ T cells are reported after back-
ground subtraction of the frequency of the identically
gated population of cells from the same sample stimulated
with uRBCs and are expressed as a percentage of total
CD4+ T cells. For the phenotypic analysis of CD4 T cell
memory subsets, the population of cells that express each
marker within the CD4 T cell population was entered into
a ‘Boolean gating’ analysis [42] that separately identifies all
the subpopulations expressing each possible combination
of markers. The frequency of each specific CD4+ T cell
subpopulation is expressed as a percentage of CD4+ T
cells. In experiments with CFSE labeled cells, the per-
centages of divided CD4+ T cells after iRBC stimulation
are reported after subtraction of the percentage of divided
CD4+ T cells after uRBC stimulation.
Luminex analysis of culture supernatants
Supernatants were thawed and immediately analyzed using
a Human Cytokine Magnetic 25-Plex assay (Invitrogen) as
recommended by the manufacturer. The following cyto-
kines were measured: IL-1β, IL-1RA, IL-2, IL-2R, IL-4,
IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40), IL-13, IL-15,
IL-17, TNF-α, INF-α, IFN-γ, GM-CSF, CCL3 (MIP-1α),
CCL4 (MIP1β), CXCL10 (IP-10), CXCL9 (MIG), Eotaxin,
CCL5 (RANTES), and CCL2 (MCP-1). Briefly, 50 μL of
culture supernatant was diluted 1:2 in medium and in-
cubated with anti-cytokine antibody-coupled magnetic
beads for 2 hours at room temperature while shaking at
500 rpm in the dark. The beads were then incubated
with 100 μL of a biotinylated detector antibody for
1 hour at room temperature, before incubation with
streptavidin R-phycoerythrin for 30 mins (between each
step, the beads were washed in wash buffer using a
magnetic separator). After a final wash, beads were re-
suspended in 125 μL of buffer and 100 beads counted
for each cytokine in a Bio-Plex MAGPIX multiplex reader
(Bio-Rad Laboratories, Inc.). Final concentrations were
calculated from the mean fluorescence intensity and
expressed in pg/mL using standard curves with known
concentrations of each cytokine.
Statistical methods
All statistical analyses were performed using Prism 6.0
(GraphPad). Mann–Whitney U-test and Kruskal–Wallis
tests were used to compare continuous variables between
two and more than two groups, respectively. Correlations
between different continuous measures were determined
using Spearman’s rank correlation coefficient. For all tests,
two-tailed P values were considered significant if P < 0.05.
Results
P. falciparum-specific CD4+ T cells are maintained in the
absence of continual exposure
To determine whether malaria-specific CD4+ T cells are
maintained in the absence of continued exposure, we
compared the frequency and function of P. falciparum-
specific CD4+ T cell responses between historically and
continually exposed children. PBMC from each group of
children were stimulated with P. falciparum-iRBC and
analyzed by flow cytometry for production of IFN-γ,
TNF-α, IL-10, and IL-4 (Fig. 1a, b). There was no signifi-
cant difference between the proportions of CD4+ T cells
producing each cytokine between the two groups of chil-
dren (IFN-γ P = 0.26, TNF-α P = 0.65, IL-10 P = 0.81, IL-4
P = 0.66), suggesting that maintenance of P. falciparum-
specific CD4+ T cells is not dependent on continual ex-
posure to the parasite (Fig. 1c). In fact, there appeared
to be a trend (though not statistically significant) to-
wards higher responses (IFN-γ and any cytokine) in the
Ngerenya cohort (i.e. historically exposed children). It
is important to note that, similar to the findings of a
study of a cohort of children from the same area [43],
the majority of children sampled from both groups
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had undetectable levels of IFN-γ/IL-10 co-producing
CD4+ T cells.
Overall memory phenotype of P. falciparum-specific
CD4+ T cells remains unchanged in the absence of
continual exposure
Persistent exposure to infection can result in significant
remodeling of the T cell population, changing the rela-
tive frequencies of different memory subsets with poten-
tially significant immunological consequences [44, 45].
Even subtle differences in environmentally driven T cell ac-
tivation can result in phenotypic and functional changes to
the T cell compartment [46]. To assess whether the pheno-
type of P. falciparum-specific CD4+ T cells changed with
declining exposure to P. falciparum, we compared the sur-
face phenotype of P. falciparum-specific CD4+ T cells (pro-
ducing IFN-γ in response to P. falciparum) isolated
from each group of children (Fig. 2). Once again, we
did not observe any significant differences between the
two groups for any of the T cell memory subsets we
examined. This would suggest that not only is the size
of the P. falciparum-specific CD4+ T cell population
maintained in the absence of exposure, but the overall
memory differentiation profile of the population is also
maintained.
P. falciparum-specific T cell proliferation is significantly
enhanced after period of minimal exposure
P. falciparum-specific T cell proliferation has been shown
to be impaired in heavily exposed children [8, 15]. While
the frequency and memory phenotype of P. falciparum-
specific CD4+ T cells appear to be unaffected by a decline
in exposure, we were interested in whether P. falciparum-
specific proliferative responses would differ based on
a
b c
Fig. 1 P. falciparum-specific CD4+ T cells are maintained in the absence of continual exposure to P. falciparum. a Gating strategy to identify live
CD4+ T cells. b Intracellular cytokine staining assay demonstrating CD4+ T cell response of one representative child to stimulation with P. falciparum-
infected RBCs (iRBC), negative controls: media and uninfected RBC (uRBC) and positive control: plate-bound anti-CD3 (α-CD3). Shown is CD4+ T cell
production of IFN-γ and IL-10 (upper panel) as well as IL-4 and TNF-α (lower panel). c Overall frequency of CD4+ T cells producing any cytokine, IFN-γ,
TNF-α, IL-10, and IL-4, respectively. P. falciparum-specific cytokine production was calculated as percentage of CD4+ T cells producing a particular
cytokine following iRBC stimulation minus uRBC stimulation. Blue dots represent historically-exposed children living in Ngerenya (n = 44), while red
squares represent continually exposed children living in Junju (n = 44). Horizontal black lines indicated the median response for each group. No
statistically significant differences were observed between historically and continually exposed children, as assessed by Mann–Whitney U test
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levels of recent exposure. We compared proliferation of
P. falciparum-specific CD4+ T cells between historically
(n = 37) and continually (n = 37) exposed children fol-
lowing stimulation with iRBC. Prior reports [34] have
described non-specific proliferation of T cells in res-
ponse to Pf antigens. Therefore, we also included samples
from malaria-naïve (based on weekly active surveillance
since enrollment into cohort at or soon after birth) chil-
dren of similar age (n = 8). P. falciparum-specific CD4+ T
cell proliferation was significantly higher in historically ex-
posed children than in those who have been continually
exposed (P = 0.016) (Fig. 3a). In keeping with previous
reports of exposure dependent impairment of T cell
proliferation [47–49], P. falciparum-specific CD4+ T
cell proliferation in continually exposed children was
not significantly different from the level of proliferation
observed in malaria-naïve children. When we compared
the proliferation of CD4+ T cells between the three
groups after non-specific stimulation with plate-bound
anti-CD3 (Fig. 3b), CD4+ T cells from all three groups
proliferated to similar levels confirming that the dif-
ference in proliferation was unique to P. falciparum-
specific T cells and not representative of widespread
suppression of the whole CD4+ T cell population. This
result suggests that P. falciparum-specific CD4+ T cell
proliferative impairment is dependent on continued
exposure to the parasite and is lost after a period of
minimal exposure.
P. falciparum-inducible pro-inflammatory cytokines are
upregulated in historically exposed relative to continually
exposed children
In addition to inhibiting P. falciparum-specific T cell
proliferation, repeat exposure to malaria has been shown
to downregulate the expression of several cytokines asso-
ciated with malaria-inducible inflammation [7]. To assess
whether the enhanced CD4+ T cell proliferation we ob-
served in historically exposed children was indicative of
an enhanced malaria-inducible inflammatory response, we
compared P. falciparum-inducible cytokine levels in su-
pernatants from a subset of iRBC-stimulated PBMCs from
each group using a multiplex assay. Of the 25 cytokines
assayed, eight (CCL2, IL-6, CCL5, CCL3, CCL4, IL-1RA,
CXCL10, and CXCL9) were expressed at levels above a
quantifiable limit of 40 pg/mL. While CCL2 was the most
abundant P. falciparum-inducible cytokine, there was no
significant difference in its expression between historically
and continually exposed children (Fig. 4a). We did, how-
ever, find that expression of the pro-inflammatory cyto-
kines, IL-6, CXCL9, and CXCL10 were significantly higher
in historically exposed than continually exposed children
(IL-6 P <0.05, CXCL9 P <0.01, CXCL10 P <0.01), while
the anti-inflammatory cytokine IL-1RA was downregu-
lated in historically exposed children relative to con-
tinually exposed children (Fig. 4b). A number of other
cytokines (IL-4, IL-13, IL-10, IL-15, IL-5, IFN-γ, and IL-17)
were detected at levels too low to be precisely quantified by
Fig. 2 Memory phenotype of P. falciparum-specific CD4 + T cell population maintained in absence of continual exposure. Differential expression of
CCR7, CD27, and CD45RO by P. falciparum-specific CD4+ T cells (producing IFN-γ upon stimulation with P. falciparum-infected red blood cells). Each
phenotype (defined by a specific combination of markers) is shown beneath the X-axis. Where a specific phenotype has been ascribed to a particular
differentiation stage, this is specified. TCM and TEM refer to central memory and effector memory cell populations, respectively. The frequency of each
subset is expressed as a percentage of the total IFN-γ+ CD4+ T cell population and was compared between historically exposed children (Ngerenya)
and continually exposed children (Junju). Horizontal black lines represent median responses in each group. Mann–Whitney U-test was used for
pairwise analysis of differences between groups – no significant differences were observed. Pie charts illustrate relative proportions of each of
the combinations of markers in the two groups of children
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standard curve; however, we were able to compare their
relative levels between groups by comparing the mean
fluorescence intensities detected. In agreement with the
profile exhibited by the more highly expressed cyto-
kines, we found significantly higher levels of the pro-
inflammatory cytokines, IFN-γ, IL-5, IL-13, IL-15, and
IL-17 in historically exposed than continually exposed
children (Additional file 2: Figure S1). These results would
suggest that the mechanism(s) responsible for restraining
P. falciparum-inducible inflammation observed in highly
exposed individuals is lost following a period of minimal
exposure, resulting in a more pronounced inflammatory
response upon re-exposure.
P. falciparum-specific CD4+ T cell proliferation correlates
with recent clinical malaria in continually exposed
children
Since it has previously been demonstrated that there is a
strong relationship between P. falciparum-specific T cell
function and time elapsed since last malaria episode
a b
Fig. 4 P. falciparum- induced pro-inflammatory cytokine production enhanced after period of minimal exposure. Peripheral blood mononuclear
cells isolated from children with little current exposure to malaria (Blue bars, Ngerenya, n = 15), continually exposed children (Red bars, Junju,
n = 15), and malaria-naïve children (Black bars, n = 5) were stimulated for 7 days with P. falciparum-infected or uninfected red blood cells (iRBC or
uRBC). Culture supernatants were collected and analyzed using a multiplex assay for 25 cytokines. P. falciparum-specific cytokine production was
calculated as concentration of cytokine following iRBC stimulation minus uRBC stimulation. Results are shown for cytokines which were detected
at a net concentration ≥ 40 pg/mL. a Concentration of P. falciparum-induced CCL2 in each group. b Concentration of P. falciparum-specific IL-6,
CCL5, CCL3, CCL4, IL-1RA, CXCL10, and CXCL9 in each group. Bars indicate mean cytokine concentration (pg/mL) with standard error of the mean (SEM)
also indicated. Statistically significant differences (*P< 0.05, **P< 0.01) are indicated by asterisk (in red for Kruskal–Wallis or black for Mann–Whitney
U-tests, respectively)
a b
Fig. 3 P. falciparum-specific CD4+ T cell proliferation enhanced after period of minimal exposure. Proportion of P. falciparum-specific CD4+ T cells
proliferating in response to iRBC stimulation is significantly higher in children with little current exposure to malaria (Blue dots, Ngerenya, n= 37)
compared to continually exposed children (Red squares, Junju, n= 37) and malaria-naïve children (Black triangles, n= 8). P. falciparum-specific proliferation
was calculated as percentage of CFSE-lo CD4+ T cells following iRBC stimulation minus uRBC stimulation. Non-specific CD4+ T cell proliferation in response
to plate-bound anti-CD3 stimulation was also compared across the three groups. Statistically significant P values (P < 0.05) are indicated by asterisk
(in red for Kruskal–Wallis or black for Mann–Whitney U-tests, respectively)
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[15], we were interested in determining whether this
relationship is maintained after a period of minimal ex-
posure. We observed a strong positive correlation between
P. falciparum-specific CD4+ T cell proliferation and the
duration since last clinical episode of malaria (Spearman’s
Rho= 0.34, P = 0.04) in continually exposed children
(Fig. 5a), with more recent malaria associated with
lower CD4+ T cell proliferation. However, no statisti-
cally significant association was observed between P.
falciparum-specific CD4+ T cell proliferation and dur-
ation since last clinical malaria episode (Spearman’s
Rho = –0.005, P = 0.98) in historically exposed children
(Fig. 5b). While all the children were asymptomatic at
blood draw, approximately one third of continually ex-
posed children were determined to be parasite positive
by PCR. Interestingly, we did not find an association
between asymptomatic parasitemia and CD4+ T cell
proliferation (Additional file 3: Figure S2). Variations in
P. falciparum-specific CD4+ T cell proliferation can
thus be explained by duration since last clinical episode in
continually exposed children but not historically exposed
children, providing further evidence that P. falciparum-
specific CD4+ T cell proliferative impairment is lost in the
absence of continued exposure.
Discussion
In this study, we sought to determine the effect that
declining exposure to P. falciparum has on previously
acquired P. falciparum-specific T cell immunity by com-
paring two cohorts of otherwise similar children with
different levels of current exposure. We demonstrate
that, while P. falciparum-specific CD4+ T cells are
maintained at similar levels and with similar memory
phenotype after a significant period (median: 8.7 years;
interquartile range: 4.1–9.1 years) of minimal exposure
to the parasite, the proliferative capacity of these cells
appeared to be altered considerably. In keeping with
previous reports [8, 15], we found evidence of signifi-
cantly impaired CD4+ T cell proliferation in continually
exposed children, with levels of P. falciparum-specific
CD4+ T cell proliferation in these children indistinguish-
able from the levels in malaria-naïve children. In contrast,
after a period of minimal exposure, P. falciparum-specific
CD4+ T cells proliferated robustly upon re-stimulation in
vitro, suggesting that the regulatory mechanism respon-
sible for inhibiting P. falciparum-specific CD4+ T cell
proliferation is dependent on exposure to the parasite.
Importantly, this exposure-dependent inhibition of
CD4+ T cell proliferation was restricted to P. falciparum-
specific CD4+ T cells, since the levels of CD4+ T cell pro-
liferation in response to anti-CD3 stimulation were similar
across the three groups.
While we did not find an association between asymp-
tomatic parasitemia and CD4+ T cell proliferation, we
did find a significant positive association between dur-
ation since last febrile episode and P. falciparum-specific
CD4+ T cell proliferation (in continually exposed chil-
dren), with more recent febrile episodes associated with
lower proliferation. This result is in agreement with a re-
cent study of seasonal malaria in Mali, where successive
exposure to P. falciparum resulted in downregulation of
pro-inflammatory responses and an upregulation of cyto-
kines responsible for control of inflammation [7]. While
that study did not assess P. falciparum-specific CD4+ T cell
proliferation, our finding that PBMCs from historically ex-
posed children express higher levels of pro-inflammatory
cytokines (including IL-6, IL-5, CXCL9, and CXCL10), but
lower levels of anti-inflammatory cytokines (including
a b
Fig. 5 Variations in T cell proliferation can be explained by duration since last episode in continually exposed children but not historically exposed
children. a Proliferation of P. falciparum-specific CD4+ T cells is positively associated with days since last clinical malaria episode in continually exposed
children (Junju) Spearman’s Rho= 0.338, P = 0.0408. b P. falciparum-specific CD4+ T cell proliferation does not correlate with days since last clinical
malaria episode in children with little current exposure (Ngerenya) Spearman’s Rho = -0.005, P = 0.976
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IL-1RA) than continually exposed children following
re-stimulation with P. falciparum suggests that impaired
P. falciparum-specific CD4+ T cell proliferation is a fur-
ther reflection of malaria-induced immunoregulation.
Interestingly, IL-6, CXCL9, and CXCL10 have all been
demonstrated to stimulate T cell proliferation [50–52],
with IL-6 in particular also promoting T cell survival
and inhibiting activation-induced cell death [53]. Fur-
thermore, IL-1RA, which we found to be elevated in
continually exposed children relative to historically ex-
posed children, has been found to inhibit T cell responses
to antigenic stimulation [54]. We acknowledge the
findings of a recent study reporting a decline in malaria
antigen specific- IFN-γ, IL-10, and TNF-α responses in in-
dividuals following a period of low exposure; however, the
profile of cytokine responses reported in that study varied
substantially by antigen and the reported decline in cyto-
kine levels was not always maintained beyond 6 months of
follow-up. Importantly, that study measured cytokine re-
sponses to individual peptide antigens, while we measured
the response to the whole parasite. The gap in exposure
reported was also significantly shorter than in our study,
suggesting that, while there might be antigen-specific fluc-
tuations in cytokine levels over short periods of low ex-
posure, the cytokine response profile after longer gaps in
exposure may be altered significantly.
Our results provide clear evidence that (1) P. falciparum-
specific CD4+ T cells are maintained in the absence of con-
tinual exposure to the parasite, (2) continual exposure to P.
falciparum induces a strong immunoregulatory response
capable of dampening infection-associated inflammation,
and (3) P. falciparum-specific CD4+ T cell proliferation
(following in vitro stimulation) is significantly enhanced
after a period of minimal exposure. While future studies
will be needed to precisely define these mechanisms, our
data suggests that the mechanisms responsible for me-
diating malaria-induced immunoregulation (potentially
critical for NAI) could be lost in the absence of continual
exposure to the parasite. Such mechanisms are likely to
involve regulatory T cells [55, 56] and atypical/exhausted
lymphocytes [9, 10] that have been shown to expand with
continuous exposure to malaria.
As we have mentioned previously, immune individuals
who migrate to malaria-free regions for prolonged pe-
riods may become susceptible to clinical disease upon
re-exposure, but still demonstrate less severe outcomes
than malaria-naïve individuals [20–22]. Such individuals
mount robust inflammatory responses to relatively few
parasites [21, 57], suggesting that they retain some ability
to control parasite replication but are unable to modulate
malaria-induced inflammation [22]. Considered in the
context of our data and existing knowledge about how
malaria infection modulates several components of the
immune system, these epidemiologic observations suggest
a model by which clinical immunity is lost in absence
of exposure to P. falciparum. We hypothesize that
malaria-naïve individuals who become infected with P.
falciparum are unable to control parasite growth result-
ing in inflammation and associated acute febrile illness.
Continually exposed individuals are able to restrict
parasite growth (mediated in large part by antibody-
dependent mechanisms) and also able to modulate
parasite-induced inflammation and T cell proliferation,
allowing them to remain afebrile despite the persistence
of low level parasitemia. Historically exposed individ-
uals, on the other hand, are capable of limiting parasite
growth but have lost the ability to modulate parasite-
induced inflammation, resulting in an exaggerated
inflammatory reaction and acute febrile illness in re-
sponse to relatively few parasites. The precise mechan-
ism of malaria-induced immunoregulation remains to
be investigated and likely involves both innate and
adaptive components. Future work will need to assess
the possible contributions of “malaria toxin”-induced
TLR hypo-responsiveness [58], as well as more T cell
intrinsic changes that may explain the observed loss of
clinical immunity with lack of exposure. One significant
caveat of this study is that we are unable to determine
whether the immunoregulation observed in historically
exposed children represents a decline of pre-established
immunoregulatory mechanisms or a failure to ad-
equately develop these mechanisms under conditions of
declining exposure. Longitudinal cohort studies and
controlled human challenge experiments in naturally
immune populations will be needed to fully investigate
this question.
Conclusions
The last decade has seen vast investments in malaria
control and the associated decline in transmission is
reason to be encouraged. However, the heterogeneous
nature of this decline [2] may leave large populations
of previously protected individuals susceptible to clini-
cal disease. This is particularly important if a popula-
tion of children emerge who have lost the ability to
control the inflammatory response to malaria and are
therefore at higher risk of illness. Furthermore, such
pre-existing immune regulation may be responsible for
the observed reductions in immunogenicity for malaria
experimental vaccines in malaria-exposed populations
relative to malaria naïve ones [37]. Understanding the
mechanisms of P. falciparum-induced immunoregula-
tion, the role that this plays in NAI, and how immunity
is affected by a decline in exposure will be critical in
the design and implementation of an effective vaccine,
which remains the best long-term preventative measure
against malaria.
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Additional file 1: Table S1. Flow cytometry staining panels. (XLSX 8 kb)
Additional file 2: Figure S1. Relative amounts of P. falciparum-induced
cytokines in historically and continually exposed children. Peripheral
blood mononuclear cells were isolated from children with little current
exposure to malaria (Blue bars, Ngerenya, n = 15) compared to continually
exposed children (Red bars, Junju, n = 15) and malaria-naïve children
(Black bars, n= 5). Culture supernatants were analyzed using a multiplex assay
for 25 cytokines. P. falciparum-specific cytokine production was calculated as
mean fluorescent intensity (MFI) of following P. falciparum-infected red blood
cell stimulation minus uninfected red blood cell stimulation. Results are shown
for cytokines that were detected at levels that precluded precise quantification
by standard curve. Bars indicate MFI with standard error of the mean (SEM)
also indicated. Statistically significant differences (*P < 0.05, **P < 0.01) are
indicated by asterisk (in red for Kruskal–Wallis or black for Mann–Whitney
U-tests, respectively). (PDF 67 kb)
Additional file 3: Figure S2. Proliferation of P. falciparum-specific CD4+
T cells in continually exposed children is unaffected by asymptomatic
parasitemia. Proportion of P. falciparum-specific CD4+ T cells proliferating
in response to P. falciparum-infected red blood cells (iRBC) does not differ
based on parasite status. P. falciparum-specific proliferation in continually
exposed children was calculated as percentage of CFSE-lo CD4+ T cells
following iRBC stimulation minus uRBC stimulation. Children were stratified
according to parasite status at blood draw (determined by PCR); red squares
represent children who were positive for parasites and black squares represent
children who were parasite free. No statistically significant differences were
observed as assessed by Mann–Whitney U test. (PDF 42 kb)
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